Skip to main content
. Author manuscript; available in PMC: 2020 Oct 22.
Published in final edited form as: Clin Cancer Res. 2009 Dec 15;16(1):240–248. doi: 10.1158/1078-0432.CCR-09-0986

Fig. 2.

Fig. 2.

Kaplan-Meier curve comparing overall survival for AKT, p-eIF4E, and various combinations of AKT and p-eIF4E: worse survival for p-eIF4E–positive patients (blue line) compared with p-eIF4E–negative patients (red line; A), worse survival for p-AKT–positive patients (blue line) compared with p-AKT–negative patients (red line; B), and worse survival for patients with a combination of p-AKT and p-eIF4E–positive tumors (green line; n = 83) compared with those with a combination of p-AKT– and p-eIF4E–negative tumors (red line; n = 31) and the other patients (blue line; n = 108; C).